Singleton David A, Noble P J M, Sánchez-Vizcaíno Fernando, Dawson Susan, Pinchbeck Gina L, Williams Nicola J, Radford Alan D, Jones Philip H
Epidemiology and Population Health, Institute of Infection and Global Health, University of Liverpool, Neston, United Kingdom.
Institute of Veterinary Science, University of Liverpool, Neston, United Kingdom.
Front Vet Sci. 2019 Jul 2;6:218. doi: 10.3389/fvets.2019.00218. eCollection 2019.
Canine acute diarrhoea is frequently observed in first opinion practice, though little is known about commonly used diagnostic or therapeutic management plans, including use of antimicrobials. This retrospective observational study utilised electronic health records augmented with practitioner-completed questionnaires from 3,189 cases (3,159 dogs) collected from 179 volunteer veterinary practices between April 2014 and January 2017. We used multivariable analysis to explore factors potentially associated with pharmaceutical agent prescription, and resolution of clinical signs by 10 days post-initial presentation. Use of bacteriological and/or parasitological diagnostic tests were uncommon (3.2% of cases, 95% confidence interval, CI, 2.4-4.0), though systemic antimicrobials were the most commonly prescribed pharmaceutical agents (49.7% of cases, 95% CI 46.1-53.2). Such prescription was associated with haemorrhagic diarrhoea (odds ratio, OR, 4.1; 95% CI 3.4-5.0), body temperature in excess of 39.0°C, or moderate/severe cases (OR 1.3, 95% CI 1.1-1.7). Gastrointestinal agents (e.g., antacids) were prescribed to 37.7% of cases (95% CI 35.4-39.9), and were most frequently prescribed to vomiting dogs regardless of presence (OR 46.4, 95% CI 19.4-110.8) or absence of blood (OR 17.1, 95% CI 13.4-21.9). Endoparasiticides/endectocides were prescribed to 7.8% of cases (95% CI 6.8-9.0), such prescription being less frequent for moderate/severe cases (OR 0.5, 95% CI 0.4-0.7), though more frequent when weight loss was recorded (OR 3.4, 95% CI 1.3-9.0). Gastrointestinal nutraceuticals (e.g., probiotics) were dispensed to 60.8% of cases (95% CI 57.1-64.6), these cases less frequently presenting with moderate/severe clinical signs (OR 0.6, 95% CI 0.5-0.8). Nearly a quarter of cases were judged lost to follow-up (=754). Insured (OR 0.7, 95% CI 0.5-0.9); neutered (OR 0.4, 95% CI 0.3-0.5), or vaccinated dogs (OR 0.3, 95% CI 0.3-0.4) were less commonly lost to follow-up. Of remaining dogs, clinical signs were deemed resolved in 95.4% of cases (95% CI 94.6-96.2). Provision of dietary modification advice and gastrointestinal nutraceuticals alone were positively associated with resolution (OR 2.8, 95% CI 1.3-6.1); no such associations were found for pharmaceutical agents, including antimicrobials. Hence, this study supports the view that antimicrobials are largely unnecessary for acute diarrhoea cases; this being of particular importance when considering the global threat posed by antimicrobial resistance.
犬急性腹泻在初诊实践中经常出现,然而对于常用的诊断或治疗管理方案,包括抗菌药物的使用,我们却知之甚少。这项回顾性观察研究利用了电子健康记录,并辅以从179家志愿兽医诊所收集的、由从业者填写的问卷,这些数据来自2014年4月至2017年1月期间的3189例病例(3159只犬)。我们采用多变量分析来探究与药物处方以及初次就诊后10天内临床症状缓解可能相关的因素。细菌学和/或寄生虫学诊断测试的使用并不常见(3.2%的病例,95%置信区间,CI,2.4 - 4.0),尽管全身性抗菌药物是最常开具的药物(49.7%的病例,95% CI 46.1 - 53.2)。这种处方与出血性腹泻相关(比值比,OR,4.1;95% CI 3.4 - 5.0)、体温超过39.0°C或中度/重度病例相关(OR 1.3,95% CI 1.1 - 1.7)。胃肠道药物(如抗酸剂)被开给37.7%的病例(95% CI 35.4 - 39.9),并且无论是否有血,最常被开给呕吐的犬(有血时OR 46.4,95% CI 19.4 - 110.)。内寄生虫驱虫剂/内外寄生虫驱虫剂被开给7.8%的病例(95% CI 6.8 - 9.0),这种处方在中度/重度病例中较少见(OR 0.5,95% CI 0.4 - 0.7),不过当记录到体重减轻时更常见(OR 3.4,95% CI 1.3 - 9.0)。胃肠道营养保健品(如益生菌)被发放给60.8%的病例(95% CI 57.1 - 64.6),这些病例出现中度/重度临床症状的频率较低(OR 0.6,95% CI 0.5 - 0.8)。近四分之一的病例被判定失访(=754)。参保犬(OR 0.7,95% CI 0.5 - 0.9);绝育犬(OR 0.4,95% CI 0.3 - 0.5)或接种疫苗的犬(OR 0.3,95% CI 0.3 - 0.4)失访的情况较少见。在其余的犬中,95.4%的病例(95% CI 94.6 - 96.2)临床症状被认为已缓解。仅提供饮食调整建议和胃肠道营养保健品与症状缓解呈正相关(OR 2.8,95% CI 1.3 - 6.1);对于包括抗菌药物在内的药物,未发现此类关联。因此,本研究支持这样一种观点,即抗菌药物对于急性腹泻病例在很大程度上是不必要的;在考虑到抗菌药物耐药性所带来的全球威胁时,这一点尤为重要。